1. Accueil >
  2. Vistin Pharma ASA: Mandatory notification of trade >
Nasdaq

Vistin Pharma ASA: Mandatory notification of trade

20-02-2026

Magnus Tolleshaug, Chief Executive Officer in Vistin Pharma ASA, and a primary insider, has on 20'th of February 2026 purchased 30.000 shares in Vistin Pharma ASA at an average price of NOK 21,10 per share. Following this purchase Magnus Tolleshaug holds 105.000 shares in Vistin Pharma ASA.

 

Attachment